These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8049655)

  • 41. The role of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia.
    Fenaux P
    Acta Haematol; 1993; 89 Suppl 1():22-7. PubMed ID: 8475669
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical pharmacology of all-trans retinoic acid (ATRA)].
    Robak T
    Acta Haematol Pol; 1995; 26(3):269-77. PubMed ID: 8525772
    [TBL] [Abstract][Full Text] [Related]  

  • 43. All-trans retinoic acid and short-time, high-dose cytarabine in two children with acute promyelocytic leukemia.
    Schmitt K; Zoubek A; Schwarz R; Tulzer G; Koller E; Krieger O; Lutz D; Gadner H
    Med Pediatr Oncol; 1996 Apr; 26(4):254-7. PubMed ID: 8600337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo evidence of all-trans retinoic acid inducing maturation in acute promyelocytic leukaemia.
    Hamidah HN; Cheong SK; Ainoon O
    Acta Haematol; 1993; 89(1):50-1. PubMed ID: 8480488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Coagulopathy and differentiation syndrome: the main complications of the initial treatment of acute promyelocytic leukemia].
    Korístek Z; Zák P
    Vnitr Lek; 2008; 54(7-8):745-50. PubMed ID: 18780573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [All-trans retinoic acid (Tretinoin)].
    Ohno R
    Gan To Kagaku Ryoho; 1997 Apr; 24(6):741-6. PubMed ID: 9126315
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage.
    Hashimoto S; Koike T; Tatewaki W; Seki Y; Sato N; Azegami T; Tsukada N; Takahashi H; Kimura H; Ueno M
    Leukemia; 1994 Jul; 8(7):1113-5. PubMed ID: 8035603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extensive splenic infarction, deep vein thrombosis and pulmonary emboli complicating induction therapy with all-trans-retinoic acid (ATRA) for acute promyelocytic leukemia.
    Goldschmidt N; Gural A; Ben Yehuda D
    Leuk Lymphoma; 2003 Aug; 44(8):1433-7. PubMed ID: 12952241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Morbidity and costs of remission induction therapy with all-trans retinoic acid compared with standard chemotherapy in acute promyelocytic leukemia.
    Eardley AM; Heller G; Warrell RP
    Leukemia; 1994 Jun; 8(6):934-9. PubMed ID: 8207987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Remission induction of acute promyelocytic leukemia by all-trans-retinoic acid: molecular evidence of restoration of normal hematopoiesis after differentiation and subsequent extinction of leukemic clone.
    Ohashi H; Ichikawa A; Takagi N; Hotta T; Naoe T; Ohno R; Saito H
    Leukemia; 1992 Aug; 6(8):859-62. PubMed ID: 1353552
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of acute promyelocytic leukemia with trans-retinoic acid. Experience of the Santa Maria Hospital, Medical School of Lisbon].
    De Lacerda JF; Do Carmo JA; De Moura MC; Guerra ML; Lopes C; Raposo J; Melo A; De Oliveira JJ; De Lacerda JM
    Acta Med Port; 1994 Dec; 7(12):717-24. PubMed ID: 7717119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience.
    Warrell RP; Maslak P; Eardley A; Heller G; Miller WH; Frankel SR
    Leukemia; 1994; 8 Suppl 2():S33-7. PubMed ID: 7815834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The present status in all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia patients: further understanding and comprehensive strategy are required in the future.
    Chen ZX; Tao RF; Xia XM
    Leuk Lymphoma; 1992 Nov; 8(4-5):247-52. PubMed ID: 1290955
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retinoic acid syndrome induced by arsenic trioxide in treating recurrent all-trans retinoic acid resistant acute promyelocytic leukemia.
    Che-Pin Lin ; Huang MJ; Chang IY; Lin WY; Sheu YT
    Leuk Lymphoma; 2000 Jun; 38(1-2):195-8. PubMed ID: 10811463
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
    Zhou GB; Zhang J; Wang ZY; Chen SJ; Chen Z
    Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):959-71. PubMed ID: 17317642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effective methyl prednisolone pulse therapy for a patient with retinoic acid syndrome in acute promyelocytic leukemia].
    Matsuda S; Saitoh Y; Kanbayashi H; Tanaka T; Sakuma H; Maruyama Y; Ohno R
    Rinsho Ketsueki; 1993 Sep; 34(9):1033-8. PubMed ID: 8230747
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retinoic acid syndrome: a case report.
    Tsao HM; Hsu HC
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Nov; 60(5):273-6. PubMed ID: 9509683
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Induction therapy of acute promyelocytic leukemia with all-trans retinoic acid: a case, followed by conventional post-remission chemotherapy in complete remission].
    Tsukada T; Mahmud N; Taniguchi M; Takahashi T; Kihira H; Kita K; Kobayashi T; Deguchi K; Shirakawa S
    Rinsho Ketsueki; 1992 Dec; 33(12):1880-3. PubMed ID: 1479702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia.
    Chen SJ; Zelent A; Tong JH; Yu HQ; Wang ZY; Derré J; Berger R; Waxman S; Chen Z
    J Clin Invest; 1993 May; 91(5):2260-7. PubMed ID: 8387545
    [TBL] [Abstract][Full Text] [Related]  

  • 60. All-trans-retinoic acid in acute promyelocytic leukemia.
    Tallman MS; Andersen JW; Schiffer CA; Appelbaum FR; Feusner JH; Ogden A; Shepherd L; Willman C; Bloomfield CD; Rowe JM; Wiernik PH
    N Engl J Med; 1997 Oct; 337(15):1021-8. PubMed ID: 9321529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.